CCLD · CareCloud, Inc.

CareCloud’s Q1 2026 results reflect continued top-line momentum—revenue grew 13% year-over-year to $31.3 million—while near-term earnings pressure emerged from non-recurring Medsphere integration costs and elevated amortization of acquired intangibles, reducing GAAP net income to $922,000 from $1.9 million in Q1 2025. Adjusted EBITDA declined modestly to $5.4 million, but management explicitly attributed this to transitional expenses that were largely eliminated by quarter-end and are expected to subside going forward. The Company reaffirmed its full-year 2026 guidance across all key metrics—revenue ($128–$132M), Adjusted EBITDA ($29–$31M), and GAAP EPS ($0.20–$0.23)—signaling confidence in underlying operational execution and margin expansion trajectory. Strategic developments underpinning the outlook include the announced full cash redemption of Series B Preferred Stock on May 15, 2026; the successful integration of Medsphere (closed August 2025); and commercial traction from AI initiatives—including stratusAI Desk Agent automating ~75% of inbound patient calls and stratusAI Voice Audit delivering real-time revenue and compliance insights. Expansion into the inpatient segment via its #1 Black Book–ranked EDIS platform further broadens CareCloud’s total addressable market. These developments collectively signal a pivot toward scalable, technology-led growth with a simplified capital structure and strengthened balance sheet—key prerequisites for sustained shareholder value creation through the remainder of 2026.